A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/138 (2006.01) A61K 31/18 (2006.01) A61K 31/517 (2006.01) A61P 15/04 (2006.01)
Patent
CA 2588017
Use of an alpha-adrenergic blocker for the preparation of a medicament for treating primary dysmenorrhea in a human female suffering from the same. Exemplary alpha-adrenergic blockers are phenoxybenzamine, alfuzosin, doxazosin, terazosin, prazosin, and tamsulsoin, or a pharmaceutically acceptable salt or ester thereof. Tamsulosin HC1 is preferred.
L'invention concerne une méthode permettant de traiter une dysménorrhée primaire qui consiste à administrer à une femme souffrant de dysménorrhée une quantité thérapeutiquement efficace d'un bloqueur adrénergique alpha. Les bloqueurs adrénergiques alpha pris en exemple sont la phénoxybenzamine, l'alfuzosine, la doxazosine, la térazosine, la prazosine et la tamsulosine ou un sel ou un ester pharmaceutiquement acceptable de celles-ci. Le bloqueur préféré est la tamsulosine HC1.
Boehringer Ingelheim Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Use of alpha-adrenergic blockers for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of alpha-adrenergic blockers for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of alpha-adrenergic blockers for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1831088